Matthew Angel
President and CEO at Ernexa Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Ernexa Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Ernexa Therapeutics Inc. June 16, 202399.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 24, 2026 | Tempest Therapeutics Inc. | Open-market purchase | +231,482 | $2.16 | $500,001 |
| Mar 24, 2026 | Tempest Therapeutics Inc. | Open-market purchase | +231,482 | $2.16 | $500,001 |
Questions about Matthew Angel
What boards is Matthew Angel on?
Matthew Angel sits on the boards of Ernexa Therapeutics Inc. and Tempest Therapeutics Inc.
What company is Matthew Angel the CEO of?
Matthew Angel has been CEO and President of Tempest Therapeutics Inc. since February 2026.
How long has Matthew Angel served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.